🔎 Trials Near Me

Home › Blood Cancers › Minnesota › Rochester

Blood Cancers clinical trials in Rochester, MN

7 studies for Blood Cancers are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

RecruitingObservational study
  • Mayo Clinic in Rochester, Rochester
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

RecruitingPhase 1/2
  • Mayo Clinic, Rochester
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

RecruitingPhase 1/2
  • Mayo Clinic, Rochester
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078

Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

RecruitingObservational study
  • Mayo Clinic, Rochester
All ages · All sexes · Updated Apr 1, 2026 · NCT02457962

Role of Gut Microbiome in Cancer Therapy

RecruitingObservational study
  • Mayo Clinic in Rochester, Rochester
Ages 18 to 99 · All sexes · Updated Mar 16, 2026 · NCT05112614

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RecruitingPhase 1
  • Mayo Clinic - Rochester, Rochester
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT05735184

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Recruiting
  • Mayo Clinic in Rochester, Rochester
Ages 18 and older · All sexes · Updated Feb 23, 2026 · NCT02958462

Blood Cancers trials in other cities

Other studies in Rochester

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.